These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38293112)

  • 1.
    Weinberg ZY; Soliman SS; Kim MS; Shah DH; Chen IP; Ott M; Lim WA; El-Samad H
    bioRxiv; 2024 Aug; ():. PubMed ID: 38293112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel cells enable genetic detection of SARS-CoV-2 Spike protein.
    Weinberg ZY; Hilburger CE; Kim M; Cao L; Khalid M; Elmes S; Diwanji D; Hernandez E; Lopez J; Schaefer K; Smith AM; Zhou F; ; Kumar GR; Ott M; Baker D; El-Samad H
    bioRxiv; 2021 Apr; ():. PubMed ID: 33907743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and Sensitive Detection of Antigen from SARS-CoV-2 Variants of Concern by a Multivalent Minibinder-Functionalized Nanomechanical Sensor.
    Agarwal DK; Hunt AC; Shekhawat GS; Carter L; Chan S; Wu K; Cao L; Baker D; Lorenzo-Redondo R; Ozer EA; Simons LM; Hultquist JF; Jewett MC; Dravid VP
    Anal Chem; 2022 Jun; 94(23):8105-8109. PubMed ID: 35652578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent designed proteins protect against SARS-CoV-2 variants of concern.
    Hunt AC; Case JB; Park YJ; Cao L; Wu K; Walls AC; Liu Z; Bowen JE; Yeh HW; Saini S; Helms L; Zhao YT; Hsiang TY; Starr TN; Goreshnik I; Kozodoy L; Carter L; Ravichandran R; Green LB; Matochko WL; Thomson CA; Vögeli B; Krüger-Gericke A; VanBlargan LA; Chen RE; Ying B; Bailey AL; Kafai NM; Boyken S; Ljubetič A; Edman N; Ueda G; Chow C; Addetia A; Panpradist N; Gale M; Freedman BS; Lutz BR; Bloom JD; Ruohola-Baker H; Whelan SPJ; Stewart L; Diamond MS; Veesler D; Jewett MC; Baker D
    bioRxiv; 2021 Jul; ():. PubMed ID: 34268509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.
    Cao L; Goreshnik I; Coventry B; Case JB; Miller L; Kozodoy L; Chen RE; Carter L; Walls L; Park YJ; Stewart L; Diamond M; Veesler D; Baker D
    bioRxiv; 2020 Aug; ():. PubMed ID: 32793905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants.
    Han Y; Yang Z; Hu H; Zhang H; Chen L; Li K; Kong L; Wang Q; Liu B; Wang M; Lin J; Chen PR
    J Am Chem Soc; 2022 Apr; 144(13):5702-5707. PubMed ID: 35212528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Protein Engineering in Biomedical Applications of Mammalian Synthetic Biology.
    Bojar D; Fussenegger M
    Small; 2020 Jul; 16(27):e1903093. PubMed ID: 31588687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein.
    Weißenborn L; Richel E; Hüseman H; Welzer J; Beck S; Schäfer S; Sticht H; Überla K; Eichler J
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia.
    Jarisch A; Wiercinska E; Huenecke S; Bremm M; Cappel C; Hauler J; Rettinger E; Soerensen J; Hellstern H; Klusmann JH; Ciesek S; Bonig H; Bader P
    Transplant Cell Ther; 2022 Jul; 28(7):366.e1-366.e7. PubMed ID: 35472554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: Immunological characteristics of
    Morita A; Imagawa K; Tagawa M; Sakamoto N; Takada H
    Front Immunol; 2023; 14():1107808. PubMed ID: 36875135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection.
    Vecchio E; Rotundo S; Veneziano C; Abatino A; Aversa I; Gallo R; Giordano C; Serapide F; Fusco P; Viglietto G; Cuda G; Costanzo F; Russo A; Trecarichi EM; Torti C; Palmieri C
    J Transl Med; 2024 Jan; 22(1):33. PubMed ID: 38185632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.
    Cao L; Goreshnik I; Coventry B; Case JB; Miller L; Kozodoy L; Chen RE; Carter L; Walls AC; Park YJ; Strauch EM; Stewart L; Diamond MS; Veesler D; Baker D
    Science; 2020 Oct; 370(6515):426-431. PubMed ID: 32907861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein.
    Costa CFS; Barbosa AJM; Dias AMGC; Roque ACA
    Biotechnol Adv; 2022 Oct; 59():107986. PubMed ID: 35598822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Protein Micelles to Block Transduction by SARS-CoV-2 Pseudovirus.
    Chattaraj R; Kim CY; Lee D; Hammer DA
    ACS Nano; 2022 Oct; 16(10):17466-17477. PubMed ID: 36191145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives.
    Jin H; Gong Y; Cheng L; Zhu Y; Zhang Z; He Y
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Computational Design of Small-Molecule-Controlled Protein-Based Circuits for Synthetic Biology.
    Kretschmer S; Kortemme T
    Proc IEEE Inst Electr Electron Eng; 2022 May; 110(5):659-674. PubMed ID: 36531560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells.
    Luo H; Wu X; Sun R; Su J; Wang Y; Dong Y; Shi B; Sun Y; Jiang H; Li Z
    Front Oncol; 2019; 9():1448. PubMed ID: 31921693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric Antigen Receptors Expand the Repertoire of Antigenic Macromolecules for Cellular Immunity.
    Keane JT; Posey AD
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Receptors for Sensing Soluble Molecules with Mammalian Cells.
    Scheller L
    Methods Mol Biol; 2021; 2312():15-33. PubMed ID: 34228282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Immunotherapy: Programming Immune Cells with Novel and Sophisticated Logic Capabilities.
    Lam CK; Hyde RK; Patel SA
    Transplant Cell Ther; 2022 Sep; 28(9):560-571. PubMed ID: 35691572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.